The dataset demonstrates that clearance rates increased between Day 29 and Day 57, consistent with continued biological activity over time. The 200µg cohort demonstrated the highest observed activity ...

Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarter2025 year-end cash and cash equivalents of $226.

Rein expects to enroll patients through mid-2027, with interim data anticipated in the second half of 2026.

Introduction Intensive care unit (ICU) visiting restrictions in hospitals, implemented due to infection control and other factors, limited contact between patients and family members, affecting ...

An international, randomized, double-blind, placebo-controlled Phase III study—the largest of its kind for mpox—found that tecovirimat did not improve clinical outcomes for adults with clade II mpox ...

Supplements for muscle recovery include creatine, turmeric, and vitamin C. Many athletes use these to improve performance and ...

This transition is explored in “Embodied Artificial Intelligence in Healthcare: A Systematic Review of Robotic Perception, ...

How do we take on and resolve vein-related pelvic pain in women? PeVD has been associated with venous-origin chronic pelvic ...

This recording was made using enhanced software. But in science, that’s only the starting point. Before you believe the next health headline, watch the video above. Download the SAN app today to stay ...

The rapid proliferation of algorithmic systems has sparked widespread concerns about their potential to perpetuate and ...

Researchers led by Mika Kivimaki and Staffan Nyberg at University College London have linked obesity to roughly one in 10 ...

Huntington Beach, California - February 24, 2026 - PRESSADVANTAGE - A newly released educational resource provides a ...